NJR makes a strong case for investment, given its growth prospects, strong ROE and capability to increase shareholders' value.
Vous n'êtes pas connecté
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates make the stock attractive
NJR makes a strong case for investment, given its growth prospects, strong ROE and capability to increase shareholders' value.
TDY makes a strong case for investment in the aerospace sector, given its long-run growth prospects, low debt and strategic acquisitions.
NWN makes a strong case for investment, given its growth prospects, better debt management and capability to increase shareholders' value.
NWN makes a strong case for investment, given its growth prospects, better debt management and capability to increase shareholders' value.
SJW makes a strong case for investment, given its growth prospects, prudent debt management and capability to increase shareholder value.
SJW makes a strong case for investment, given its growth prospects, prudent debt management and capability to increase shareholder value.
GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.
GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.
XEL makes a strong case for investment given its growth prospects, strong ROE, highly efficient operations and capability to increase shareholders'...
BIIB's reasonable valuation, an improving pipeline and better sales prospects of new drugs are good enough reasons to stay invested for now.